Clinical trials
Completed Observational Hypertension, Pulmonary trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
180 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 5 |
| 2006 | 7 |
| 2007 | 8 |
| 2008 | 8 |
| 2009 | 9 |
| 2010 | 6 |
| 2011 | 14 |
| 2012 | 11 |
| 2013 | 9 |
| 2014 | 13 |
| 2015 | 11 |
| 2016 | 13 |
| 2017 | 16 |
| 2018 | 13 |
| 2019 | 5 |
| 2020 | 5 |
| 2021 | 6 |
| 2022 | 1 |
| 2023 | 6 |
| 2024 | 3 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 180 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 15 |
| Medical University of Graz | 11 |
| University of Zurich | 8 |
| National Heart, Lung, and Blood Institute (NHLBI) | 6 |
| University of Giessen | 5 |
| Northwell Health | 4 |
| Assiut University | 3 |
| GlaxoSmithKline | 3 |
| Mayo Clinic | 3 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension, Pulmonary | 180 |
| Pulmonary Arterial Hypertension | 27 |
| Heart Failure | 14 |
| Anemia, Sickle Cell | 10 |
| Pulmonary Disease, Chronic Obstructive | 9 |
| Hypoxia | 7 |
| Lung Diseases, Interstitial | 6 |
| Lung Diseases | 5 |
| Scleroderma, Diffuse | 5 |
| Ventricular Dysfunction, Left | 5 |
Trials
Showing 1 to 25 of 180. Each trial links to its page on Pharma Observatory.
80 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.